Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Sandra Panem"'
Autor:
Sandra Panem
Publikováno v:
Nature. 343:521-522
Autor:
Sandra Panem
Publikováno v:
Science. 263:1299-1299
Autor:
Susan S. Addiss, Sandra Panem
Publikováno v:
Journal of Public Health Policy. 11:118
AIDS is unquestionably the most serious threat to public health in this century--yet how effective has the United States been in coping with this deadly disease? This sobering analysis of the first five years of the AIDS epidemic reveals the failure
Autor:
Charles Weissmann, Sandra Panem, Marco Schwarzstein, Ned Mantei, Shigekazu Nagata, Michel Streuli
Publikováno v:
Gene. 10:1-10
We have determined the nucleotide sequence of the human leukocyte interferon cDNA carried in hybrid plasmid Z-pBR322(Pst)/HcIF-2h, which has been shown to direct the formation of a polypeptide with human leukocyte interferon activity (Nagata et al.,
Autor:
Sandra Panem
Publikováno v:
JAMA: The Journal of the American Medical Association. 247:418a-421
The First Annual International Congress for Interferon Research, held in Washington, DC, during the fall of 1980, left the impression that interferon as an anticancer drug was intriguing but unproved (JAMA [MEDICAL NEWS] 1981;245:109-116).The second
Publikováno v:
Journal of Virology. 15:1323-1331
2-Deoxy-D-glucose (2-DG) inhibited the release of transforming Kirsten murine sarcoma-leukemia virus [KiMSV(KiMuLV)] from transformed rat kidney (NRK-K) cells. At a concentration of 30 mM 2-DG, RNA synthesis in NRK-K cells was inhibited by approximat
Publikováno v:
Journal of General Virology. 50:247-257
Summary The biological and antigenic properties of HEL-12 virus have been compared with gibbon ape lymphosarcoma virus (GALV) and simian sarcoma and simian sarcoma-associated viruses, SiSV and SSAV, respectively. HEL-12 virus did not transform human
Autor:
Sandra Panem
Publikováno v:
Virology. 76:146-151
Inhibition of Kirsten murine sarcoma-leukemia virus [KiMSV(KiMuLV)l release from chronically infected normal rat kidney cells (NRK-K) by cytochalasin B (CB) was dose dependent. Concentrations of CB between 10–25 μg/ml inhibited virus release witho